February 3, 2006-- A recent analysis of the prospective, population-based Rotterdam Study found that prolongation of the heart-rate corrected QT (QTc) interval increased the risk of sudden cardiac ...

Please provide your email address to receive an email when new articles are posted on . When combined with sotalol, the oral contraceptive drospirenone was associated with QTc prolongation, a marker ...

Objective: To assess health care practitioners' ability to correctly measure the QT interval, and to identify factors and medications that may increase the risk of QT-interval prolongation and ...

Uncertainty remains regarding the value of heart-rate-corrected QT interval (QTc) prolongation on electrocardiogram for predicting cardiovascular disease (CVD), particularly among Asian populations.

The QT interval is the time from the beginning of the QRS complex (ventricular depolarization) to the end of the T wave (ventricular repolarization). The normal QT interval is controversial and ...

SSRIs (selective serotonin reuptake inhibitors), types of antidepressants, are associated with a long QT interval, researchers from Massachusetts General Hospital, Boston, reported in the BMJ (British ...

Findings in Nature Genetics support the idea that balance between sodium and potassium are essential to the heart. An international group of scientists identified 10 genes connected to changes in QT ...

As more consumer-facing devices add features to measure the heart’s electrical activity, companies are looking for new ways to turn this data into valuable health information. AliveCor, a startup that ...

Austedo and Austedo XR are prescribed to treat chorea related to Huntington’s disease and tardive dyskinesia in adults. They can cause side effects ranging from mild, such as drowsiness and insomnia, ...

The Food and Drug Administration (FDA) has approved updated labeling for Sustiva (efavirenz capsules and tablets; Bristol-Myers Squibb) to include a warning regarding QTc prolongation. The updated ...

Effect of ketoconazole on the pharmacokinetics and pharmacodynamics of ixabepilone No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2006 ASCO Annual ...